Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Abstract 6407: PTPN22-based immunotherapy yields near-complete response against PDAC via multi-pronged immune modulation

Soren Charmsaz, Nicole E. Gross, George W. Apostol, Jae W. Lee, Jianping Lin, Alexei G. Hernandez, Erin M. Coyne, Sarah M. Shin, Courtney Cannon, Xuan Yuan, James M. Leatherman, Daniel J. Zabransky, Mark Yarchoan, Zhong-Yin Zhang, Elizabeth M. Jaffee, Won Jin Ho

Cancer Res (2025) 85 (8_Supplement_1): 6407.

https://doi.org/10.1158/1538-7445.AM2025-6407

Published: 21 April 2025

View articletitled, Abstract 6407: PTPN22-based immunotherapy yields near-complete response against PDAC via multi-pronged immune modulation

Journal Articles

Abstract 5399: Placental gene PEG10 promotes onco-fetal metabolic reprogramming in hepatocellular carcinoma

Dong Yin, Xinyi Yao, Jingyuan Zhang, Yin Zhang, Jianyou Liao, Kaishun Hu, Jiehua He, Daning Lu

Cancer Res (2025) 85 (8_Supplement_1): 5399.

https://doi.org/10.1158/1538-7445.AM2025-5399

Published: 21 April 2025

View articletitled, Abstract 5399: Placental gene PEG10 promotes onco-fetal metabolic reprogramming in hepatocellular carcinoma

Journal Articles

Abstract PO5-22-02: Evaluation of a surface-guided and tattoo-less approach to setup for whole breast radiotherapy

Xinxin Zhang, Swati Mamidanna, Yin Zhang, Xiao Wang, Ning Yue, Shicha Kumar, Lindsay Potdevin, Maria Kowzun, Mridula George, Lara Hathout, Bruce Haffty, Nisha Ohri

Cancer Res (2024) 84 (9_Supplement): PO5-22-02.

https://doi.org/10.1158/1538-7445.SABCS23-PO5-22-02

Published: 02 May 2024

View articletitled, Abstract PO5-22-02: Evaluation of a surface-guided and tattoo-less approach to setup for whole breast radiotherapy

Journal Articles

Abstract 4505: Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy

Zihan Qu, Yunpeng Bai, Jiajun Dong, Zheng Zhang, Bo Huang, Yiming Miao, Andy W. Tao, Philip S. Low, Zhong-Yin Zhang

Cancer Res (2024) 84 (6_Supplement): 4505.

https://doi.org/10.1158/1538-7445.AM2024-4505

Published: 22 March 2024

View articletitled, Abstract 4505: Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy

Journal Articles

Abstract 1973: Discovery of the first-in-class SHP1 covalent inhibitor for cancer immunotherapy

Zihan Qu, Frederick Nguele Meke, Zheng Zhang, Yunpeng Bai, Aaron D. Krabill, Christine S. Muli, Brenson A. Jassim, Jiajun Dong, Jinyue Li, Nguyen Yuyen, Andy W. Tao, Darci T. Trader, Zhong-Yin Zhang

Cancer Res (2024) 84 (6_Supplement): 1973.

https://doi.org/10.1158/1538-7445.AM2024-1973

Published: 22 March 2024

View articletitled, Abstract 1973: Discovery of the first-in-class SHP1 covalent inhibitor for cancer immunotherapy

Journal Articles

Abstract 4687: Primary study on the anticancer role of BAM15 in lung cancer cells

Mei-yin Zhang, Yue-Ning Wang, Yu-Feng Zhou, Shuo-Cheng Wang, Shi-Juan Mai, Hui-Yun Wang

Cancer Res (2024) 84 (6_Supplement): 4687.

https://doi.org/10.1158/1538-7445.AM2024-4687

Published: 22 March 2024

View articletitled, Abstract 4687: Primary study on the anticancer role of BAM15 in lung cancer cells

Journal Articles

Abstract 5306: PTPN22 targeting partners with 41BB/OX40 costimulation to overcome anti-PD1 resistance in pancreatic ductal adenocarcinoma

Soren Charmsaz, Nicole E. Gross, Jae W. Lee, Jianping Lin, Alexei G. Hernandez, Erin M. Coyne, Sarah M. Shin, Courtney Cannon, Xuan Yuan, Zhong-Yin Zhang, Elizabeth M. Jaffee, Won Jin Ho

Cancer Res (2024) 84 (6_Supplement): 5306.

https://doi.org/10.1158/1538-7445.AM2024-5306

Published: 22 March 2024

View articletitled, Abstract 5306: PTPN22 targeting partners with 41BB/OX40 costimulation to overcome anti-PD1 resistance in pancreatic ductal adenocarcinoma

Journal Articles

Abstract 6141: Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer: A prospective cohort study

Yin Zhang, Yuxi Liu, Kathryn L. Penney, Sara Lindström, Peter Kraft

Cancer Res (2024) 84 (6_Supplement): 6141.

https://doi.org/10.1158/1538-7445.AM2024-6141

Published: 22 March 2024

View articletitled, Abstract 6141: Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer: A prospective cohort study

Journal Articles

Abstract 1969: Off-target autophagy inhibition by SHP2 allosteric inhibitors and therapeutic implications for aberrant RAS-driven cancers

Yiming Miao, Yunpeng Bai, Jinmin Miao, Allison A. Murray, Jianping Lin, Jiajun Dong, Zihan Qu, Ruo-Yu Zhang, Quyen Nguyen, Shaomeng Wang, Zhong-Yin Zhang

Cancer Res (2024) 84 (6_Supplement): 1969.

https://doi.org/10.1158/1538-7445.AM2024-1969

Published: 22 March 2024

View articletitled, Abstract 1969: Off-target autophagy inhibition by SHP2 allosteric inhibitors and therapeutic implications for aberrant RAS-driven cancers

Journal Articles

Abstract CT026: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies

Cancer Res (2023) 83 (8_Supplement): CT026.

https://doi.org/10.1158/1538-7445.AM2023-CT026

Published: 14 April 2023

View articletitled, Abstract CT026: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies

Journal Articles

Abstract LB154: Circ0003039 interacts with calreticulin to inhibit the progression of hepatocellular carcinoma by suppressing wnt/beta-catenin signaling pathway

Yue-Ning Wang, Yu-Feng Zhou, Ji Liu, Mei-Yin Zhang, Shuo-Cheng Wang, Shi-Juan Mai, Hui-Yun Wang

Cancer Res (2023) 83 (8_Supplement): LB154.

https://doi.org/10.1158/1538-7445.AM2023-LB154

Published: 14 April 2023

View articletitled, Abstract LB154: Circ0003039 interacts with calreticulin to inhibit the progression of hepatocellular carcinoma by suppressing wnt/beta-catenin signaling pathway

Journal Articles

PINK1-Mediated Mitophagy Promotes Oxidative Phosphorylation and Redox Homeostasis to Induce Drug-Tolerant Persister Cancer Cells

Yun Li, Hengxing Chen, Xuan Xie, Bing Yang, Xiaojuan Wang, Jingyuan Zhang, Tian Qiao, Jiao Guan, Yuntan Qiu, Yong-Xin Huang, Duanqing Tian, Xinyi Yao, Daning Lu, H. Phillip Koeffler, Yin Zhang, Dong Yin

Cancer Res (2023) 83 (3): 398–413.

https://doi.org/10.1158/0008-5472.CAN-22-2370

Published: 03 February 2023

View articletitled, PINK1-Mediated Mitophagy Promotes Oxidative Phosphorylation and Redox Homeostasis to Induce Drug-Tolerant Persister Cancer Cells

Includes: Supplementary data

Journal Articles

Abstract 5934: Weight loss and subsequent cancer diagnosis: A prospective cohort study

Qiao-Li Wang, Ana Babic, Michael H. Rosenthal, Alice A. Lee, Yin Zhang, Xuehong Zhang, Mingyang Song, Leandro F. Rezende, Dong Hoon Lee, Leah Biller, Kimmie Ng, Andrew T. Chan, Meir J. Stampfer, Edward L. Giovannucci, Peter Kraft, Chen Yuan, Brian M. Wolpin

Cancer Res (2022) 82 (12_Supplement): 5934.

https://doi.org/10.1158/1538-7445.AM2022-5934

Published: 15 June 2022

View articletitled, Abstract 5934: Weight loss and subsequent cancer diagnosis: A prospective cohort study

Journal Articles

Abstract LB091: Long-term statin use and risk of colorectal cancer: A prospective cohort study

Yin Zhang, Andrew T. Chan, Jeffrey A. Meyerhardt, Edward L. Giovannucci

Cancer Res (2021) 81 (13_Supplement): LB091.

https://doi.org/10.1158/1538-7445.AM2021-LB091

Published: 01 July 2021

View articletitled, Abstract LB091: Long-term statin use and risk of colorectal cancer: A prospective cohort study

Journal Articles

Abstract 1416: Long non-coding RNA GAN1 inhibits tumor progression by regulating the mir-26a/PTEN axis in lung cancer

Rui-qi Wang, Xiao-Ran Long, Mei-Yin Zhang, Dong-Ni Chen, Zhe-Sheng Wen, Shi-Juan Mai, Hui-Yun Wang

Cancer Res (2020) 80 (16_Supplement): 1416.

https://doi.org/10.1158/1538-7445.AM2020-1416

Published: 15 August 2020

View articletitled, Abstract 1416: Long non-coding RNA GAN1 inhibits tumor progression by regulating the mir-26a/PTEN axis in lung cancer

Journal Articles

Abstract 3398: PTPN22 is a systemic target for augmenting antitumor immunity

Won Jin Ho, Jianping Lin, Ludmila Danilova, Zaw Phyo, Soren Charmsaz, Aditya Mohan, Todd Armstrong, Ben H. Park, Elana J. Fertig, Zhong-Yin Zhang, Elizabeth M. Jaffee

Cancer Res (2020) 80 (16_Supplement): 3398.

https://doi.org/10.1158/1538-7445.AM2020-3398

Published: 15 August 2020

View articletitled, Abstract 3398: PTPN22 is a systemic target for augmenting antitumor immunity

Journal Articles

Abstract 3392: Personal use of permanent hair dyes and cancer risk and mortality in US women: Prospective cohort study

Yin Zhang, Brenda Birmann, Jiali Han, Edward Giovannucci, Frank Speizer, Meir Stampfer, Bernard Rosner, Eva Schernhammer

Cancer Res (2020) 80 (16_Supplement): 3392.

https://doi.org/10.1158/1538-7445.AM2020-3392

Published: 15 August 2020

View articletitled, Abstract 3392: Personal use of permanent hair dyes and cancer risk and mortality in US women: Prospective cohort study

Journal Articles

Abstract 3702: A lineage-specific lncRNA driven by Foxa1 associated super enhancer promotes tumor growth through interacting YBX1

Yin Zhang, Yong-xin Huang, Dan-lan Wang, Hai-yan Yan, Yin Dong

Cancer Res (2020) 80 (16_Supplement): 3702.

https://doi.org/10.1158/1538-7445.AM2020-3702

Published: 15 August 2020

View articletitled, Abstract 3702: A lineage-specific lncRNA driven by Foxa1 associated super enhancer promotes tumor growth through interacting YBX1

Journal Articles

Abstract 5977: Maf1 suppresses hepatocarcinogenesis in mice through inhibition of Akt-mTOR signaling

Di Cao, Xiaoxing Li, Yang Yang, Yu-Feng Zhou, Mei-Yin Zhang, Shan-Shan Zhang, Qian-Nan Ren, Hui-Zhong Zhang, Yao-Jun Zhang, Shi-Juan Mai, Hui-Yun Wang

Cancer Res (2020) 80 (16_Supplement): 5977.

https://doi.org/10.1158/1538-7445.AM2020-5977

Published: 15 August 2020

View articletitled, Abstract 5977: Maf1 suppresses hepatocarcinogenesis in mice through inhibition of Akt-mTOR signaling

Journal Articles

Abstract P4-12-20: Early toxicity and patient-reported cosmetic outcomes in patients treated with adjuvant proton-based radiotherapy after breast-conserving surgery

Mutlay Sayan, Yin Zhang, Bo Liu, Apar Gupta, Bruce Haffty, Nisha Ohri

Cancer Res (2020) 80 (4_Supplement): P4-12-20.

https://doi.org/10.1158/1538-7445.SABCS19-P4-12-20

Published: 15 February 2020

View articletitled, Abstract P4-12-20: Early toxicity and patient-reported cosmetic outcomes in patients treated with adjuvant proton-based radiotherapy after breast-conserving surgery

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 6407: PTPN22-based immunotherapy yields near-complete response against PDAC via multi-pronged immune modulation

Abstract 5399: Placental gene PEG10 promotes onco-fetal metabolic reprogramming in hepatocellular carcinoma

Abstract PO5-22-02: Evaluation of a surface-guided and tattoo-less approach to setup for whole breast radiotherapy

Abstract 4505: Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy

Abstract 1973: Discovery of the first-in-class SHP1 covalent inhibitor for cancer immunotherapy

Abstract 4687: Primary study on the anticancer role of BAM15 in lung cancer cells

Abstract 5306: PTPN22 targeting partners with 41BB/OX40 costimulation to overcome anti-PD1 resistance in pancreatic ductal adenocarcinoma

Abstract 6141: Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer: A prospective cohort study

Abstract 1969: Off-target autophagy inhibition by SHP2 allosteric inhibitors and therapeutic implications for aberrant RAS-driven cancers

Abstract CT026: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies

Abstract LB154: Circ0003039 interacts with calreticulin to inhibit the progression of hepatocellular carcinoma by suppressing wnt/beta-catenin signaling pathway

PINK1-Mediated Mitophagy Promotes Oxidative Phosphorylation and Redox Homeostasis to Induce Drug-Tolerant Persister Cancer Cells

Abstract 5934: Weight loss and subsequent cancer diagnosis: A prospective cohort study

Abstract LB091: Long-term statin use and risk of colorectal cancer: A prospective cohort study

Abstract 1416: Long non-coding RNA GAN1 inhibits tumor progression by regulating the mir-26a/PTEN axis in lung cancer

Abstract 3398: PTPN22 is a systemic target for augmenting antitumor immunity

Abstract 3392: Personal use of permanent hair dyes and cancer risk and mortality in US women: Prospective cohort study

Abstract 3702: A lineage-specific lncRNA driven by Foxa1 associated super enhancer promotes tumor growth through interacting YBX1

Abstract 5977: Maf1 suppresses hepatocarcinogenesis in mice through inhibition of Akt-mTOR signaling

Abstract P4-12-20: Early toxicity and patient-reported cosmetic outcomes in patients treated with adjuvant proton-based radiotherapy after breast-conserving surgery

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only